Envía por correo este artículo 
Insuficiencia renal relacionada a alteraciones metabólicas y endocrinas
Resumen
Introducción: La insuficiencia renal es descrita como un problema de salud pública mundial relacionado a una alta mortalidad y morbilidad con respecto al riesgo de la enfermedad renal crónica. Objetivo: Identificar las alteraciones metabólicas y endocrinas en pacientes con insuficiencia renal y las comorbilidades clínicas asociadas. Metodología: La investigación fue de diseño mixto, el tipo de estudio fue descriptivo y de revisión sistemática. Resultados: Los resultados evidenciaron en un estudio de EE. UU. (2023) que el 6,2% de los 103766 casos presentaron acidosis metabólica, descrita como la alteración con mayor frecuencia. Un estudio de Japón (2023) evidencio que el 50,4% de los 26626 casos presentaron insuficiencia cardíaca, descrita como la comorbilidad más frecuente. Otro estudio, realizado en Israel (2023) reflejó que, según 40558 casos registrados, la creatinina es el biomarcador más frecuente. Conclusiones: En resumen, la relación de la insuficiencia renal con las alteraciones metabólicas y endocrinas se determinó por medio de una investigación exhaustiva, concluyendo que la acidosis metabólica y la diabetes mellitus fueron delimitadas como las alteraciones más frecuentes en relación a la insuficiencia renal.
Palabras clave
Referencias
Caruana J, Vella K, Vella A, et al. A comparative study on the haemostatic changes in kidney failure patients: Pre- and post- haemodialysis and haemodiafiltration. Thrombosis Research. 2024; 242.
Mohsen IH, Raoof Jabbar M, Athraa H. Renal Failure, Types, Causes and Etiology: A Review Article. International Journal of Medical Science and Clinical Research Studies. 2023; 3(8): p. 1663–1666.
Jiménez D, Jiménez J. Global Perspectives in Acute Kidney Injury: Ecuador. Kidney360. 2022; 3(12): p. 2136-2139.
Garcia Sanchez JJ, Thompson J, Scott DA, et al. Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials. Advanced Therapeutics. 2022; 39(1): p. 193-220.
Prakashiny S, Saranya N, Samuel TR, et al. Application of delta gap equation for the assessment of metabolic acidosis in renal failure patients. Journal of Medical and Scientific Research. 2023; 11(4): p. 270-274.
Vincent-Johnson A, Scialla JJ. Importance of Metabolic Acidosis as a Health Risk in Chronic Kidney Disease. Advances in Chronic Kidney Disease. 2022; 29(4): p. 329-336.
Borghi C, Piani F. Uric acid and estimate of renal function. Let's stick together. International Journal of Cardiology. 2022; 310: p. 157-158.
Luo Y, Song Q, Li J, et al. Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis. BMC Nephrol. 2024; 25(1): p. e63.
Nayak M, Chaudhari HV. A Study of Biochemical Abnormalities of Thyroid Function Test in Chronic Renal Failure Patients. Journal of Evidence Based Medicine and Healthcare. 2020; 7(3): p. 108-113.
León-Figueroa DA, Aguirre-Milachay E, Barboza JJ, et al. Prevalence of hypertension and diabetes mellitus in Peruvian patients with chronic kidney disease: a systematic review and meta-analysis. BMC Nephrology. 2024; 25(1): p. e160.
Yang L, Ye N, Bian W, et al. Efficacy of medication therapy for patients with chronic kidney disease and heart failure with preserved ejection fraction: a systematic review and meta-analysis. International Urology and Nephrology. 2022; 54(6): p. 1435-1444.
Kamdem F, Bika Léle EC, Hamadou B, et al. Prevalence and risk factors of pre-hypertension and high blood pressure among adolescents in Cameroonian schools. The Journal of Clinical Hypertension. 2023; 25: p. 845-852.
Ahmed T, Lamoureux-Lamarche C, Berbiche D, et al. The association between anemia and depression in older adults and the role of treating anemia. Brain and Behavior. 2023; 13: p. e2973.
Safari S, Ghasemi M, Yousefifard M, et al. Uric acid in predicting the traumatic rhabdomyolysis induced acute kidney injury; a systematic review and meta-analysis. BMC Nephrology. 2024; 25(1): p. e82.
Kashani K, Rosner MH, Ostermann M. Creatinine: From physiology to clinical application. European Journal of Internal Medicine. 2020; 72: p. 9-14.
Chávez-Íñiguez JS, Maggiani-Aguilera P, González-Barajas D, et al. Urea Reduction in Acute Kidney Injury and Mortality Risk. Kidney and Blood Pressure Research. 2023; 48(1): p. 357-366.
Šálek T, Vodička M, Gřiva M. Cystatin C may be better than creatinine for digoxin dosing in older adults with atrial fibrillation. Journal of Clinical Laboratory Analysis. 2020; 34: p. e23427.
Ten Cate O. The Ethics of Health Professions Education Research: Protecting the Integrity of Science, Research Subjects, and Authorship. Academic Medicine. 2022; 97(1): p. 13-17.
Sari R, Yabanoglu H, Hargura AS, et al. Outcomes of Total Parathyroidectomy with Autotransplantation versus Subtotal Parathyroidectomy Techniques for Secondary Hyperparathyroidism in Chronic Renal Failure. Journal of the College of Physicians and Surgeons--pakistan : JCPSP. 2020; 30(1): p. 18-22.
Yadav G, Dabas A, Mantan M, et al. Hypothyroidism in Children with Chronic Kidney Disease Attending a Tertiary Care Center. Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2021; 32(6): p. 1722-1726.
Li CH, Lee CL, Hsieh YC, et al. Hyperuricemia and diabetes mellitus when occurred together have higher risks than alone on all-cause mortality and end-stage renal disease in patients with chronic kidney disease. BMC Nephrology. 2022; 23(1): p. e157.
Mufti NU, Khan RM, Haseeb A, et al. Hyperuricemia in Patients with Chronic Renal Failure: A Single Center Study, Pakistan. Pakistan Journal of Medical & Health Sciences. 2022; 16(5): p. 634-637.
Villasís-Keever MA, Zurita-Cruz JN, Barradas-Vázquez AS, et al. Usefulness of a nutritional strategy on dyslipidemia in pediatric patients with terminal chronic kidney disease. Nutricion Hospitalaria. 2022; 39(3): p. 530-536.
Nigassa NB, Bendiab NT. Anemia in hypertensive patients with chronic renal failure, what are the characteristics? Journal of Hypertension. 2023; 41(3): p. e259.
Mathur V, Reaven NL, Funk SE, et al. Association of body mass index with the development of metabolic acidosis in patients with chronic kidney disease. Obesity Science & Practice. 2023; 9(6): p. 609-617.
Raj R, Kumar V, Bhushan D, et al. The Prevalence of Thyroid Abnormalities in Patients With Chronic Kidney Disease: A Cross-Sectional Study at a Tertiary Care Hospital. Cureus. 2023; 15(8): p. e43065.
Chandran A, Paul BJ, Ashok VK. Thyroid Dysfunction in Chronic Kidney Disease: A Study from North Kerala. International Journal of Medical and Biomedical Studies. 2023; 7(4): p. 26-33.
Chan JYM, Islahudin F, Mohd Tahir NA. Prevalence, Risk Factors, and Management of Metabolic Acidosis in Chronic Kidney Disease Patients: A Multicenter Retrospective Study in Malaysia. Cureus. 2024; 16(3): p. e56314.
Scholz SS, Lauder L, Ewen S, et al. One-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registry. Clinical Research in Cardiology. 2020; 109(7): p. 845-856.
Gong Y, Xie L, Yu S. Long-Term In-Center Nocturnal Hemodialysis Improves Renal Anemia and Malnutrition and Life Quality of Older Patients with Chronic Renal Failure. Clinical Interventions in Aging. 2022; 17: p. 915-923.
Matsuoka-Uchiyama N, Tsuji K, Sang Y, et al. The association between hypothyroidism and proteinuria in patients with chronic kidney disease: a cross-sectional study. Scientific Reports. 2022; 12(1): p. e14999.
Hussain M, Danish Yaqoob M, Naveed Adi M, et al. A Comparative Study Of Anemia In Normal Patients And Patients With Renal Failure. Journal of Pharmaceutical Negative Results. 2023 ; 14(3).
Li F, Ye X, Yang G, et al. Relationships between blood bone metabolic biomarkers and anemia in patients with chronic kidney disease. Renal Failure. 2023; 45(1): p. e2210227.
Taha K, Catapang M, Becknell B, et al. Hypertension in children with congenital anomalies of the kidney and urinary tract. Pediatric Nephrology (Berlin, Germany). 2023; 39(4): p. 1185-1192.
Kuragano T, Okami S, Tanaka-Mizuno S, et al. Anemia Treatment, Hemoglobin Variability, and Clinical Events in Patients With Nondialysis-Dependent CKD in Japan. Kidney360. 2023; 4(9): p. 1223-1235.
Gong W, Huang J, Zhu T, et al. Functional iron deficiency anemia was associated with higher mortality in chronic kidney disease patients: the NHANES III follow-up study. Renal Failure. 2023; 45(2): p. e2290926.
Maisyaroh A, Maslufin M, Ochta Fibriyanti D, et al. Anemia and Fatigue in Patients with Chronic Kidney Failure. Jurnal Kesehatan Manarang. 2024; 10(1): p. e51.
Shavgulidze E, Papiashvili N, Jatchvadze G, et al. The Relationship Between Anemia and Parathyroid Hormone Levels in Patients With Kidney Failure Undergoing Hemodialysis Treatment in Georgia. Cureus. 2024; 16(7): p. e64021.
Li R, Wang X, Zhao X, et al. Cystatin C level is associated with the recovery of renal function in cancer patients after onset of acute kidney injury. Annals of Palliative Medicine. 2021; 10(2): p. 2158-2166.
Jeraiby M. Assessment of renal function using cystatin C and creatinine in Saudi patients after transplantation. Annals of African Medicine. 2021; 20(1): p. 59–63.
Linné E, Elfström A, Åkesson A, et al. Cystatin C and derived measures of renal function as risk factors for mortality and acute kidney injury in sepsis - A post-hoc analysis of the FINNAKI cohort. Journal of Critical Care. 2022; 72: p. e154148.
Wang CS, Pai YW, Lin CH, et al. Renal impairment is one of appropriate predictors of future diabetic peripheral neuropathy: a hospital-based 6-year follow-up study. Scientific Reports. 2022; 12(1): p. e5240.
Efros O, Beckerman P, Basson AA. Fluctuations in Serum Creatinine Levels During Hospitalization and Long-Term End-Stage Kidney Disease and Mortality. JAMA Network Open. 2023; 6(8): p. e2326996.
Lin W. Clinical Significance of Serum Creatinine, Urea Nitrogen and Uric Acid Levels in Patients with Chronic Renal Failure. International Journal of Biology and Life Sciences. 2023; 3(3): p. 19-26.
Salih Merzah K. Biochemical Markers Level in Iraqi Renal Failure Patients on Hemodialysis. Latin American Journal of Pharmacy. 2023; 42: p. 290-294.
Prezelin-Reydit M, Combe C, Fouque D, et al. Longitudinal uric acid has nonlinear association with kidney failure and mortality in chronic kidney disease. Scientific Reports. 2023; 13(1): p. e3952.
Vuijk S, Klomberg R, Hellendoorn A, et al. P274 Renal failure in children with inflammatory bowel disease. Journal of Crohn and Colitis. 2024; 18(1): p. 640–641.
Wu S, Xue W, Yu H, et al. Serum uric acid levels and health outcomes in CKD: a prospective cohort study. Nephrology Dialysis Transplantation. 2024; 39(3): p. 510-519.
Domínguez A, Álvarez C, Muñoz-Rodríguez J, et al. Prevalence of metabolic acidosis in ileal diversions more than one year after radical cystectomy and associated secondary metabolic effects. Actas Urológicas Españolas. 2023; 47(22).
Zhu W, Liu Q, Liu F, et al. High remnant cholesterol as a risk factor for developing chronic kidney disease in patients with prediabetes and type 2 diabetes: a cross-sectional study of a US population. Acta Diabetologica. 2024; 61(6): p. 735-743.
Raval NY, Valika A, Adamson PB, et al. Pulmonary Artery Pressure-Guided Heart Failure Management Reduces Hospitalizations in Patients With Chronic Kidney Disease. American Heart Association Journals. 2023; 16(5): p. e009721.
Yang Y, Zhang Z, Zhuo L, et al. The Spectrum of Biopsy-Proven Glomerular Disease in China: A Systematic Review. Chinese Medical Journal. 2020; 131(6): p. 731-735.
Meneghesso D, Bertazza Partigiani N, Spagnol R, et al. Nadir creatinine as a predictor of renal outcomes in PUVs: A systematic review and meta-analysis. Frontiers in Neurology. 2023; 11.
Wong Vega M, Swartz SJ, Devaraj S, et al. Elevated Serum Creatinine: But Is It Renal Failure? Pediatrics. 2020; 146(1): p. e20192828.
Muhsin EA, Khalaf SA, Abdulkareem AF. A study of Some Factors Affecting the Prevalence of Renal Disease in Children. Al-Kitab Journal for Pure Sciences. 2024; 8(2): p. 11-22.
Muna A, Saied I. Serum Biochemical Evaluation of Patients with Chronic Renal Failure on Hemodialysis. Yemeni Journal of Medical and Health Research. 2024; 13(1): p. 31-45.
DOI: https://doi.org/10.23857/pc.v9i10.8336
Enlaces de Referencia
- Por el momento, no existen enlaces de referencia
Polo del Conocimiento
Revista Científico-Académica Multidisciplinaria
ISSN: 2550-682X
Casa Editora del Polo
Manta - Ecuador
Dirección: Ciudadela El Palmar, II Etapa, Manta - Manabí - Ecuador.
Código Postal: 130801
Teléfonos: 056051775/0991871420
Email: polodelconocimientorevista@gmail.com / director@polodelconocimiento.com
URL: https://www.polodelconocimiento.com/
